ChemicalBook > CAS DataBase List > (-)-QUINPIROLE HYDROCHLORIDE

(-)-QUINPIROLE HYDROCHLORIDE

Product Name
(-)-QUINPIROLE HYDROCHLORIDE
CAS No.
85798-08-9
Chemical Name
(-)-QUINPIROLE HYDROCHLORIDE
Synonyms
LY-171,555;()-Quinpirole;(-)-LY 171555;(4ar-trans)-lorid;(-)-Quinpirole HCl;(-)-QUINPIROLE HYDROCHLORIDE;(?)-Quinpirole hydrochloride;(-)-quinpirole monohydrochloride;(-)-QUINPIROLE HYDROCHLORIDE (LY-171555) SELECTIVE D2 DOPAMINE;4-g)quinolone,4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1h-pyrazolo(monohydroch
CBNumber
CB4687090
Molecular Formula
C13H22ClN3
Formula Weight
255.79
MOL File
85798-08-9.mol
More
Less

(-)-QUINPIROLE HYDROCHLORIDE Property

storage temp. 
-20°C
solubility 
0.1 M HCl: soluble23mg/mL
form 
solid
color 
white
optical activity
[α]25/D 124.5°, c = 0.4 in H2O(lit.)
Water Solubility 
water: 7.3mg/mL
Stability:
Hygroscopic
More
Less

Safety

WGK Germany 
3
RTECS 
UR0809270
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
Q102
Product name
(?)-Quinpirole hydrochloride
Purity
≥98% (HPLC), solid
Packaging
10mg
Price
$153.9
Updated
2025/07/31
Sigma-Aldrich
Product number
Q102
Product name
(?)-Quinpirole hydrochloride
Purity
≥98% (HPLC), solid
Packaging
25mg
Price
$425.6
Updated
2025/07/31
Sigma-Aldrich
Product number
5.05982
Product name
(-)-Quinpirole Hydrochloride - CAS 85798-08-9 - Calbiochem
Packaging
10mg
Price
$184
Updated
2022/05/15
Sigma-Aldrich
Product number
Q102
Product name
(?)-Quinpirole hydrochloride
Purity
≥98% (HPLC), solid
Packaging
100mg
Price
$1520
Updated
2025/07/31
TRC
Product number
Q796713
Product name
(-)-QuinpiroleHydrochloride
Packaging
5mg
Price
$250
Updated
2021/12/16
More
Less

(-)-QUINPIROLE HYDROCHLORIDE Chemical Properties,Usage,Production

Uses

Antihypertensive.

Uses

(-)-Quinpirole hydrochloride has been used as a selective D2 dopamine (DA) receptor agonist in various experiments.

Biological Activity

(-)-quinpirole hydrochloride is an agonist of dopamine d2-like receptor [1].dopamine d2-like receptor reduces neuron’s excitability after activation by dopamine, making it an important drug target in schizophrenia and parkinson’s disease, but its ligands also cause cognitive inflexibility such as poor reversal learning [1, 2].in spiny neurons, (-)-quinpirole hydrochloride (5 ~ 10 μm) markedly reduced evoked firing in area x and lobus parolfactorius (lpo). unlike the enhancement of excitability by dopamine d1 receptor activation, the reduction in evoked firing by (-)-quinpirole hydrochloride was not voltage-dependent. this effect was antagonized by the dopamine d2-like receptor antagonist sulpiride (10 μm), which suggested that the effect of (-)-quinpirole hydrochloride was specific to dopamine d2-like receptor [2].in rats, (-)-quinpirole hydrochloride (0.01, 0.025, 0.1, 0.25, and 0.5 mg/kg) impaired both visual reversal learning task and spatial probabilistic reversal learning (prl) task in a dose-dependent manner. in analysis of the probe trials on the visual task, (-)-quinpirole hydrochloride at 0.25 mg/kg induced a complete blockade of learning from negative feedback, whilst learning from positive feedback was intact. estimated parameters from the model that best described the prl choice data revealed a steep and selective decrease in learning rate from losses [1].[1]. alsiö j, phillips b u, sala-bayo j, et al. dopamine d2-like receptor stimulation blocks negative feedback in visual and spatial reversal learning in the rat: behavioural and computational evidence. psychopharmacology (berl), 2019, 236(8): 2307-2323.[2]. ding l, perkel d j. dopamine modulates excitability of spiny neurons in the avian basal ganglia. the journal of neuroscience, 2002, 22(12): 5210-5218.

Biochem/physiol Actions

Quinpirole is a dopamine agonist with high affinity for the D2 and D3 dopamine receptor subtypes. Specific [3H]quinpirole binding in rat brain was saturable, and dependent on temperature, membrane concentration, sodium concentration and guanine nucleotides. The putative D2 dopamine receptor agonist quinpirole (LY 171,555) is the most widely used D2 agonist in in vivo and in vitro studies. Quinpirole hydrochloride is an active enantiomer of (±)-quinpirole.Saturation analysis revealed high affinity binding characteristics (KD = 2.3 +/- 0.3 nM) which were confirmed by association-dissociation kinetics. The regional distribution of [3H]quinpirole binding sites roughly paralleled the distribution of [3H]spiperone binding sites, with greatest densities present in the striatum, nucleus accumbens and olfactory tubercles. A variety of drugs, most notably monoamine oxidase inhibitors (MAOls), inhibit the binding of [3H]quinpirole, but not [3H]spiperone or [3H](-)N-n-Propylnorapomorphine, in rat striatal membranes by a mechanism that does not appear to involve the enzymatic activity of MAO. Clinically antidepressant MAOIs exhibited selectivity between sites labeled by [3H]quinpirole and [3H]spiperone as did a number of structurally related propargylamines and N-acylethylenediamine derivatives and other drugs such as debrisoquin and phenylbiguanide. The MAOIs clorgyline and Ro 41-1049 were the most potent. MAOIs interact with a novel binding site that is labeled by [3H]quinpirole or that modulates [3H]quinpirole binding. This site may be associated with D2-like dopamine receptors.

in vivo

DA content is left brain biased across groups, and although this asymmetry appears greater in saline controls than all drug-treated groups, there is not a significant interaction between Side and Group. When each side is considered separately it can be seen that in the left brain structure, DA levels progressively decrease with chronic quinpirole treatment, with the QQ rats differing significantly from saline controls. In contrast, right cortical DA levels are only altered significantly (increased) by acute Quinpirole. It can be found that DOPAC levels are also left brain biased across groups. However, no significant Group or interaction effects are found. Rats receiving acute Quinpirole show a selective increase in DA content and decrease in turnover ratio, relative to either saline controls or the QS group. Sensitized (QQ) rats however, have elevated DOPAC levels in comparison to the acute quinpirole group. In striatum as well, all three measures of DA function differed significantly across groups (DA, F3,33=6.27, P=0.0020; DOPAC, F3,33=7.98, P=0.0004; turnover ratio, F3,33=16.85, P<0.0001). In the acute quinpirole rats, both DOPAC and turnover ratio are significantly reduced relative to all other groups. In QQ rats, DOPAC levels are significantly greater than all other groups, while for turnover ratio, both chronic quinpirole groups were increased compared to both chronic saline groups[1].

storage

Desiccate at -20°C

(-)-QUINPIROLE HYDROCHLORIDE Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

(-)-QUINPIROLE HYDROCHLORIDE Suppliers

Pharma Affiliates
Tel
--
Fax
--
Email
@pharmaffiliates.com
Country
India
ProdList
6754
Advantage
58
Pharmaffiliates Analytics and Synthetics P. Ltd
Tel
--
Fax
--
Email
mktg@pharmaffiliates.com
Country
India
ProdList
6739
Advantage
58

85798-08-9, (-)-QUINPIROLE HYDROCHLORIDERelated Search:


  • (4AR-TRANS)-4,4A,5,6,7,8,8A,9-OCTAHYDRO-5-PROPYL-1H-PYRAZOLO[3,4-G]QUINOLINE HYDROCHLORIDE
  • (-)-QUINPIROLE HYDROCHLORIDE
  • TRANS-(-)-4AR-4,4A,5,6,7,8,8A,9-OCTAHYDRO-5-PROPYL-1H-PYRAZOLO[3,4-G] QUINOLINE HYDROCHLORIDE
  • (4ar-trans)-lorid
  • 4-g)quinolone,4,4a,5,6,7,8,8a,9-octahydro-5-propyl-1h-pyrazolo(monohydroch
  • (-)-QUINPIROLE HYDROCHLORIDE (LY-171555) SELECTIVE D2 DOPAMINE
  • (-)-quinpirole monohydrochloride
  • trans-(–)-(4aR)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo[3,4-g]quinoline monohydrochloride
  • LY-171,555
  • (4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline:hydrochloride
  • ()-Quinpirole
  • (-)-LY 171555
  • (-)-Quinpirole HCl
  • 1H-Pyrazolo[3,4-g]quinoline,4,4a,5,6,7,8,8a,9-octahydro-5-propyl-, hydrochloride (1:1), (4aR,8aR)-
  • (4AR,8aR)-5-propyl-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline hydrochloride
  • (?)-Quinpirole hydrochloride
  • 85798-08-9